1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, September 2016 (p20)

Biotechnology Analysis & Statistics in the United States, September 2016 (p20)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

All regions

571-600 of about 1800 reports

Purchase Reports From Reputable Market Research Publishers

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States
Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016

Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) - Pipeline Review, H2 2016’, ...

  • Industries : Cancer, Therapy, Pathology, Oncology
  • Countries : United States
Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen ...

  • Industries : Pathology
  • Countries : United States
Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by GlobalData

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : United States
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by GlobalData

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" ...

  • Industries : Pathology, Cancer, Healthcare, Drug Discovery and Development
  • Countries : United States
Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein Kinase 2a or MAPK14 or EC 2.7.11.24)

Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein Kinase 2a or MAPK14 or EC 2.7.11.24)

  • $ 3500
  • Industry report
  • September 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Agrigenomics Market by Application, Sequencer Type, Objective, and Region - Global Forecast to 2021

Agrigenomics Market by Application, Sequencer Type, Objective, and Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

“The agrigenomics market is projected to grow at a CAGR of 7.8%, in terms of value” The agrigenomics market is projected to reach USD 13.56 billion by 2021. Rising funds toward agrigenomics research ...

  • Industries : Genomics, Biotechnology
  • Countries : World, Asia, Europe, United States, North America
Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...

  • Industries : Biotechnology, Genomics, Biopharmaceutical
  • Countries : World, Asia, Europe, United States, North America
Global Neurological Biomarkers Market 2016-2020

Global Neurological Biomarkers Market 2016-2020

  • $ 2500
  • Industry report
  • September 2016
  • by Infiniti Research Limited

About Biomarkers Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective ...

  • Industries : Genomics
  • Countries : United States
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : United States
GLOBAL PRENATAL & MATERNAL DIAGNOSTIC MARKET TO 2021

GLOBAL PRENATAL & MATERNAL DIAGNOSTIC MARKET TO 2021

  • $ 3800
  • Industry report
  • September 2016
  • by Kelly Scientific Publications

Prenatal tests (fetus, embryos and newborns) currently on the market analyze chromosomes, DNA, RNA, genes, and/or gene products to determine whether an abnormality is present that is causative of a specific ...

  • Industries : Genomics
  • Countries : United States
Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4950
  • Industry report
  • September 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Mesenchymal Stem Cells in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. ...

  • Industries : Biological Therapy
  • Countries : United States, World, Europe, Japan
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies ...

  • Industries : Therapy, Pharmaceutical, Pathology, Oncology, Biotechnology, Healthcare
  • Countries : United States
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals ...

  • Industries : Therapy, Cancer, Oncology, Pharmaceutical, Pathology, Biotechnology
  • Countries : United States
Fabry Disease - Pipeline Review, H2 2016

Fabry Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Fabry Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H2 2016’, provides an overview of the Fabry Disease pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Pharmaceutical, Mental Health, Healthcare
  • Countries : United States, World, Europe
Batten Disease - Pipeline Review, H2 2016

Batten Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Batten Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H2 2016’, provides an overview of the Batten Disease pipeline landscape. The report provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) ...

  • Industries : Pathology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States, World
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H2 2016

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - ...

  • Industries : Therapy, Pathology
  • Countries : United States
DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 ...

  • Industries : Therapy, Biopharmaceutical, Genomics
  • Countries : United States, World, France
Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016’, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States
Burns - Pipeline Review, H2 2016

Burns - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Burns - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Burns - Pipeline Review, H2 2016’, provides an overview of the Burns pipeline landscape. The report provides comprehensive information ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States, World, Europe
Surface Protein gp120 - Pipeline Review, H2 2016

Surface Protein gp120 - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Surface Protein gp120 - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Surface Protein gp120 - Pipeline Review, H2 2016’, provides in depth analysis on Surface Protein gp120 targeted ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Biocept Inc

Biocept Inc

  • $ 99
  • Company report
  • August 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Biocept Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and ...

  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016’, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Therapy
  • Countries : United States, World
Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Bone Marrow ...

  • Industries : Healthcare, Blood Supply, Tissue Banking and Transplantation, Health Facility, Therapy, Pathology
  • Countries : United States
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Dystrophin (DMD) - Pipeline Review, H2 2016

Dystrophin (DMD) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Dystrophin (DMD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dystrophin (DMD) - Pipeline Review, H2 2016’, provides in depth analysis on Dystrophin (DMD) targeted pipeline therapeutics. ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States, World
Myocardial Ischemia - Pipeline Review, H2 2016

Myocardial Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Myocardial Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H2 2016’, provides an overview of the Myocardial Ischemia pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World, Russian Federation
About 8600 reports

Download Unlimited Documents from Trusted Public Sources

Annual Report, February 2017

  • February 2017
    67 pages
  • Dermatological ...  

    Biotechnology  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.